Cargando…

Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19

Patients with COVID-19 are at higher risk of thrombosis due to the inflammatory nature of their disease. A higher-intensity approach to pharmacologic thromboprophylaxis may be warranted. The objective of this retrospective cohort study was to determine if a patient specific, targeted-intensity pharm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farrar, Julie E., Trujillo, Toby C., Mueller, Scott W., Beltran, Lyra, Nguyen, Cecilia, Hassell, Kathryn, Kiser, Tyree H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375286/ https://www.ncbi.nlm.nih.gov/pubmed/34410561 http://dx.doi.org/10.1007/s11239-021-02552-x

Ejemplares similares

Coagulation Factor Xa (Recombinant), Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center
por: Stevens, Victoria M., et al.
Publicado: (2019)

Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding
por: Stevens, Victoria M., et al.
Publicado: (2021)

Pharmacological thromboprophylaxis and epidural anaesthesia
por: Harsoor, SS, et al.
Publicado: (2012)

Pharmacist and Physician Collaborative Practice Model Improves Vancomycin Dosing in an Intensive Care Unit
por: Levin, Dimitriy, et al.
Publicado: (2016)

Is delaying pharmacological thromboprophylaxis associated with thromboembolic complications?
por: Padim, P, et al.
Publicado: (2015)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Therapeutic Hypothermia Following Cardiopulmonary Arrest: A Systematic Review and Meta-Analysis with Trial Sequential Analysis
por: Maclaren, Robert, et al.
Publicado: (2023)

Thromboprophylaxis in Intensive Care Unit Patients: A Literature Review
por: Ejaz, Amna, et al.
Publicado: (2018)

Hepatorenal Syndrome
por: Kiser, Tyree H.
Publicado: (2014)

Extended Thromboprophylaxis in Patients with COVID-19
por: Zhao, Wei, et al.
Publicado: (2021)

Underutilization of pharmacological thromboprophylaxis in obstetrics and gynaecology patients in the absence of a risk assessment tool
por: Zaher, Galila F.
Publicado: (2017)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

A Severe Case of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus Associated with Anti-Glutamic Acid Decarboxylase Antibodies Following Immunotherapy with Pembrolizumab
por: Kedzior, Sonya K., et al.
Publicado: (2021)

Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients
por: Novak, Alison R, et al.
Publicado: (2021)

Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID‐19 intensive care unit patients
por: Romano, Lorenzo G. R., et al.
Publicado: (2022)

Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials
por: Park, Jonghanne, et al.
Publicado: (2016)

Pharmacological Thromboprophylaxis after Major Abdominal Surgery: Should the Duration be Individualized?
por: Papageorgopoulou, Chrysanthi, et al.
Publicado: (2022)

Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial
por: Arabi, Yaseen M, et al.
Publicado: (2016)

Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration
por: Van Matre, Edward T., et al.
Publicado: (2017)

Adequate thromboprophylaxis in critically ill patients
por: Levi, Marcel
Publicado: (2010)

Perioperative thromboprophylaxis in liver transplant patients
por: De Pietri, Lesley, et al.
Publicado: (2018)

Thromboprophylaxis strategies for COVID-19 patients
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Thromboprophylaxis in Patients With Cancer and COVID-19
por: Lecumberri, Ramón, et al.
Publicado: (2022)

Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial
por: Arabi, Yaseen M., et al.
Publicado: (2016)

The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply
por: Hofmaenner, Daniel A., et al.
Publicado: (2022)

Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol
por: Cohen, Alexander Thomas, et al.
Publicado: (2011)

Renal function and thromboprophylaxis in critically ill patients
por: Scholey, Gareth M, et al.
Publicado: (2010)

Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

The impact of pharmacological thromboprophylaxis and disease-stage on postoperative bleeding following colorectal cancer surgery
por: Ohta, Hiroyuki, et al.
Publicado: (2019)

Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2022)

Thromboprophylaxis in Abdominoplasty: Efficacy and Safety of a Complete Perioperative Protocol
por: Marangi, Giovanni Francesco, et al.
Publicado: (2016)

Thromboprophylaxis in elective spinal surgery: A protocol for systematic review
por: Colomina, María J., et al.
Publicado: (2020)

Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols
por: Feelders, Richard A., et al.
Publicado: (2022)

Management of intracerebral hemorrhage–use of statins
por: Van Matre, Edward T, et al.
Publicado: (2016)

The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
por: Zhang, Chuanlin, et al.
Publicado: (2019)

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
por: Cuker, Adam, et al.
Publicado: (2022)

Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center
por: Van Matre, Edward T., et al.
Publicado: (2019)

Stroke and Thromboprophylaxis in the Era of COVID-19
por: Ma, Alice, et al.
Publicado: (2021)

Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol
por: Alonso-Coello, Pablo, et al.
Publicado: (2012)

Impact of Thromboprophylaxis Intensity on Patients’ Mortality Among Hospitalized Patients with COVID-19: A Propensity-Score Matched Study
por: Almohareb, Sumaya N, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t7q1l42h49imt8clk4jmo7o95j